Improved overall survival in melanoma with combined dabrafenib and trametinib. (Record no. 24356209)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02783 a2200817 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517002725.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201501s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1533-4406 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1056/NEJMoa1412690 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Robert, Caroline |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20150107 |
245 00 - TITLE STATEMENT | |
Title | Improved overall survival in melanoma with combined dabrafenib and trametinib. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | The New England journal of medicine |
Date of publication, distribution, etc. | Jan 2015 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 30-9 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adolescent |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Imidazoles |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indoles |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Intention to Treat Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Kaplan-Meier Estimate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Melanoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mitogen-Activated Protein Kinase Kinases |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Oximes |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Proto-Oncogene Proteins B-raf |
General subdivision | antagonists & inhibitors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyridones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Pyrimidinones |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Skin Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sulfonamides |
General subdivision | adverse effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Vemurafenib |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Young Adult |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karaszewska, Boguslawa |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schachter, Jacob |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rutkowski, Piotr |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mackiewicz, Andrzej |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Stroiakovski, Daniil |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lichinitser, Michael |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dummer, Reinhard |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grange, Florent |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mortier, Laurent |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chiarion-Sileni, Vanna |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Drucis, Kamil |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Krajsova, Ivana |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hauschild, Axel |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lorigan, Paul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Wolter, Pascal |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Long, Georgina V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Flaherty, Keith |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Nathan, Paul |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Ribas, Antoni |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Martin, Anne-Marie |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Sun, Peng |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Crist, Wendy |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Legos, Jeff |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Rubin, Stephen D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Little, Shonda M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Schadendorf, Dirk |
773 0# - HOST ITEM ENTRY | |
Title | The New England journal of medicine |
Related parts | vol. 372 |
-- | no. 1 |
-- | p. 30-9 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1056/NEJMoa1412690">https://doi.org/10.1056/NEJMoa1412690</a> |
Public note | Available from publisher's website |
No items available.